Hindustan Media Ventures Ltd (HMVL) on Monday reported a consolidated profit after tax of Rs 18 crore in the December quarter ...

The company clocked a 4% increase in net profit, which stood at ₹4.53 crore for Q2 of the ongoing financial year. This ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

In the corresponding quarter of the previous fiscal, Alembic Pharmaceuticals posted a net profit of ₹180.4 crore. The company ...

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North ...

The stock was last seen trading 5.18 per cent up at Rs 8,415.85. At this price, it has climbed 13.55 per cent in the past one ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.

MercadoLibre has robust growth with significant ad revenue gains. See why MELI stock's high P/E ratio is justified, and why ...

The company's revenue from operations jumped 25 percent year-on-year to Rs 2,319 crore during the quarter under review.

Divi's Laboratories Q3 Results: Divi's Laboratories on Monday reported an 64.5% year-on-year rise in its consolidated net profit (attributable to Shareholders of the Company) for the fiscal's third ...